To-Increase Acquires AX for Pharma

Gilde Buy Out Partners and To-Increase Management Acquire To-Increase from Columbus

December 21, 2020

Cloud & SaaS

Columbus A/S agreed to divest its software subsidiary To-Increase to Gilde Buy Out Partners alongside To-Increase management for an enterprise value of EUR 113 million. The divestment is part of Columbus' strategic refocus to become a global consultancy and is expected to close in January 2021 subject to Works Council consultation; Gilde plans to support organic growth acceleration and bolt-on M&A for To-Increase.

Aditxt Inc. Signs Share Exchange Agreement to Acquire AiPharma Global Holdings LLC

December 28, 2021

Biotechnology

Aditxt Inc. (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC, a wholly owned subsidiary of AiPharma Group Ltd., in a two-step transaction that initially transfers a 9.5% interest followed by the remaining 90.5% subject to closing conditions and shareholder/Nasdaq approvals. The deal would give Aditxt commercial presence in infectious disease therapeutics and access to AiPharma's rights to Avigan (favipiravir) and related antiviral assets and distribution networks.

Axcel (Alpine Investors) Acquires Accelebrate to Expand IT Training Portfolio

January 17, 2023

Education

Axcel, the Alpine Investors‑backed professional education platform, has acquired Accelebrate, an Atlanta‑based IT training company, and will integrate it with its IT training business Web Age Solutions. Accelebrate founder Steve Heckler will remain involved as an advisor while Accelebrate works with Tim Toomey, CEO of Web Age, to scale instructor‑led on‑site and online training for financial services, government, and technology clients.

Pfizer Acquires Amplyx Pharmaceuticals

April 28, 2021

Biotechnology

Pfizer Inc. acquired Amplyx Pharmaceuticals, a privately held clinical-stage biotechnology company developing the antifungal candidate fosmanogepix (APX001). The deal expands Pfizer's anti-infectives pipeline and secures Amplyx's lead and early-stage assets to advance development of novel antifungal and antiviral therapies.

Daxtra Acquires PivotCX

April 25, 2024

Software

Daxtra, the UK-based provider of AI-enriched recruitment software, has acquired PivotCX, an Indianapolis-based talent acquisition communications hub. The acquisition (closed April 24, 2024) will fold PivotCX’s communications capabilities into the Daxtra product suite to improve candidate engagement and conversion; terms were not disclosed.

Altasciences Acquires Alliance Contract Pharma

February 27, 2020

Pharmaceuticals

Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.